Minireviews
Copyright ©The Author(s) 2021.
World J Gastroenterol. Nov 7, 2021; 27(41): 7113-7124
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7113
Figure 2
Figure 2 Non-alcoholic fatty liver disease and extrahepatic comorbidities (i. e. inflammatory bowel disease, obstructive syndrome apnea and psoriasis) risk phenotypes. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; IBD: Inflammatory bowel disease; NAFLD: Non-alcoholic fatty liver disease; OSA: Obstructive syndrome apnea.